Tarextumab OMP 59R5 represents a significant therapeutic agent targeting Notch Two, a key protein implicated in multiple blood diseases. This human protein specifically binds to NOTCH2 , inhibiting https://rishillnd704284.blog5.net/93862881/tarextuma-omp-59r5-a-innovative-anti-notch2-antibody